Polyphron assembles all-star team from Broad, DeepMind, Ginkgo and Berkeley

darian314 · x · 2026-09-17

Following Polyphron's $20M seed announcement, founder Matthew Osman has assembled an all-star team with backgrounds from the Broad Institute, Google DeepMind, Ginkgo Bioworks and Berkeley AI, working on validating AI-created drugs with human tissue models.

Related event: Polyphron Raises $20M Seed to Build Verification Substrate for Drug Discovery(4 posts)→

Original post →

More from Companies & People

Companies & People channel →